Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MLYCD | O95822 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.39 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CCR3 | P51677 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3810771 | 0.91 | MLYCD (0.44) | SMN1; SMN2NPC1RAB9AMLYCDTDP1 | |
| SCHEMBL18113985 | 0.91 | MLYCD (0.44) | SMN1; SMN2NPC1RAB9AMLYCDTDP1 | |
| SCHEMBL4088688 | 0.88 | HPGD (0.46) | SMN1; SMN2TDP1HPGDMEN1KMT2A | |
| SCHEMBL4092474 | 0.84 | KMT2A (0.46) | SMN1; SMN2NPC1TDP1HPGDMEN1 | |
| SCHEMBL4092763 | 0.83 | MLYCD (0.41) | SMN1; SMN2MLYCDTDP1HPGDMEN1 | |
| SCHEMBL29733453 | 0.81 | MLYCD (0.42) | SMN1; SMN2NPC1RAB9AMLYCDTDP1 | |
| SCHEMBL21749700 | 0.81 | NPC1 (0.44) | SMN1; SMN2NPC1RAB9AMLYCDTDP1 | |
| SCHEMBL3807941 | 0.81 | KMT2A (0.48) | SMN1; SMN2NPC1RAB9AMLYCDTDP1 | |
| SCHEMBL3807531 | 0.81 | NPC1 (0.44) | SMN1; SMN2NPC1RAB9AMLYCDTDP1 | |
| SCHEMBL15165764 | 0.80 | MAPT (0.42) | SMN1; SMN2NPC1RAB9AMLYCDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107333780-B | Bactericidal composition and application thereof | 中化作物保护品有限公司 | 2020-03-24 | — | — | CN | disclosed |
| US-20090023667-A1 | Composition For Preventing Harmful Organisms | MITSUI CHEMICALS, INC. (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1872658-A1 | PESTICIDAL COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-20070049635-A1 | Diamine derivatives, process for producing the same, and plant disease control agents containing the same as active ingredients | MITSUI CHEMICALS, INC. (JP) | 2007-03-01 | — | — | US | disclosed |
| EP-1681285-A1 | DIAMINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PLANT DISEASE CONTROL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT | Mitsui Chemicals, Inc. (JP) | 2006-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049635-A1 | Diamine derivatives, process for producing the same, and plant disease control agents containing the same as active ingredients | HRH4, HRH1, DDT | SMN1; SMN2 3370/4885NPC1 1621/4885RAB9A 640/4885 |
| US-20090023667-A1 | Composition For Preventing Harmful Organisms | DDT, CBR3, AHR | SMN1; SMN2 3028/4885NPC1 1609/4885RAB9A 996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.